What We Do

Rx-360 protects patient safety by offering opportunities for entities across the pharmaceutical industry to collaborate on quality audits and resource development.

Joint Audit Program® 

  • Use our services to confidentially share quality audits to optimize resources and reduce redundancy.

Membership Consortium

  • Join our consortium to benefit from discounts and credits on audit program products and services, collaborate on resource development, and access leadership and speaking opportunities.

 

FIND OUT IF YOU WORK FOR A MEMBER COMPANY

What Our Members & Customers Say

“My company has made significant use of the Joint Audit Program. As a member of the Consortium, we have been able to utilize the "audit credits" benefit generated from previously sponsored joint audits to significantly reduce our out-of-pocket cost of audits we have co-sponsored or licensed this year!”
Rob Smith, Supplier Quality Audit & Compliance
GSK
Rx-360 is like an active "neighborhood watch" group that focuses on keeping the supply of medical products safe for patients worldwide. I am thankful that my company and so many of our peer and supplier companies are committed to working together on Rx-360's supply chain security mission on behalf of our patients!
Eric Berg, Director of Quality Assurance
Amgen, Inc.
Rx-360 brings valuable networking and education opportunities to my organization that operates in over 100 locations around the world, deeply involved with supply chain integrity and regulatory compliance for inbound and outbound to manufacturing and direct to patient distribution.
David Bang, CEO
JAS

Top Resources

 

Publications

Downloadable Supplier Assessment Questionnaire

October 14, 2025

simplify supplier assessments using Rx-360’s SAQ Pharmaceutical manufacturers and industry suppliers recognize the inefficiency and waste of resources when each individual pharmaceutical company creates its own supplier assessment questionnaire. Suppliers routinely exhaust valuable resources continuously […]

Patient Safety Blog

China’s Regulatory Reform Signals a New Era for Pharmaceutical Innovation

November 7, 2025

In a significant move to reshape its pharmaceutical landscape, China has unveiled a comprehensive guideline aimed at deepening the reform of drug and medical device regulation. Issued by the General Office of the State Council […]

Publications

2026 China Regulations Readiness Checklist

As China continues to evolve its pharmaceutical regulatory landscape, organizations operating within or in partnership with the Chinese market must proactively adapt to remain compliant and competitive. The National Medical Products Administration (NMPA) has outlined […]

Publications

APEC Supply Chain Security Toolkit Workshop

September 15, 2025

Get the tools you need for breaking down the barriers that hold the world back from optimal movement of critical goods and materials. Download the publication to access the video modules listed below that make […]

Patient Safety Blog

Direct-to-Patient Pharmaceutical Programs

October 15, 2025

The pharmaceutical landscape is evolving rapidly, and one of the most transformative shifts is the rise of direct-to-patient (D2P) distribution. As manufacturers seek to bypass traditional channels and deliver medications straight to patients’ doors, the […]

Latest news

JOIN OUR MAILING LIST

"*" indicates required fields

This field is for validation purposes and should be left unchanged.